Our AI instantly delivers powerful, actionable diabetes insights from one of the world’s richest diabetes datasets.
Our research explores the connection between time-in-range and mental health in people with type 1 and type 2 diabetes.
Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.
Our research found that social stigma perceptions were more common in type 1 diabetes than type 2, possibly because type 2 is less visible.
